This Honeywell Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
This Honeywell Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
View filing at SEC.gov →6 most recent filings and news items mentioning GOSS. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/GOSS/news?limit=20"
Pull GOSS filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayThis Honeywell Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
View filing at SEC.gov →Gossamer and Chiesi agreed to terminate their collaboration and license agreement, returning rights to Chiesi to pursue other development efforts, settling with post-termination payments.
View filing at SEC.gov →Gossamer Bio filed an amendment to its charter to increase authorized shares. The company intends to maintain flexibility for potential future equity offerings.
View filing at SEC.gov →Gossamer Bio announced the initial conversion rate for its 2030 notes and warrant exercise price. These calculations impact future potential dilution for investors and debt holders.
View filing at SEC.gov →Gossamer Bio announced final results of its exchange offer for 5.00% Convertible Senior Notes due 2027, with $181.052 million in principal amount tendered by the extended early tender date. The company exchanged these notes for new 7.50% Convertible Senior Secured First Lien Note
View filing at SEC.gov →Gossamer Bio extended the early tender deadline for its exchange offer of 5.00% convertible notes due 2027 for new 7.50% convertible notes, equity securities, and warrants. As of June 1, $181.052 million of the existing notes had been tendered, approaching the 98% minimum thresho
View filing at SEC.gov →